Catalyst Biosciences
$5.779876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.06 (+1.05%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours
Why Robinhood?
You can buy or sell CBIO and other stocks, options, ETFs, and crypto commission-free!
About CBIO
Catalyst Biosciences, Inc. Common Stock, also called Catalyst Biosciences, is a clinical-stage biopharmaceutical company. Read More It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
CEO
Employees
34
Headquarters
South San Francisco, California
Founded
2015
Market Cap
102.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
718.56K
High Today
$5.80
Low Today
$5.41
Open Price
$5.52
Volume
271.56K
52 Week High
$10.84
52 Week Low
$4.52
Collections
CBIO Earnings
-$1.26
-$0.84
-$0.42
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
-$1.23 per share
People Also Bought
Amarin
16,283
$14.80
+0.89%Myovant Sciences
5,395
$10.30
+7.18%Oragenics
49,837
$0.74
+26.69%Inpixon
21,958
$2.06
-5.94%Viking Therapeutics
39,896
$5.93
-0.50%Geron
31,612
$1.15
+10.58%Cassava Sciences
1,690
$5.70
-4.04%Clovis Oncology
5,036
$7.58
+10.74%Sorrento Therapeutics
12,461
$2.17
-0.46%NIO
125,858
$4.15
+0.24%Aurinia Pharmaceuticals
11,158
$17.85
+2.06%Inovio
74,146